Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.25100/cm.v51i2.4327 http://scihub22266oqcxt.onion/10.25100/cm.v51i2.4327 33012892!7518728!33012892     free     free     free       Colomb+Med+(Cali) 2020 ; 51 (2): e4327 Nephropedia Template TP {{tp|p=33012892|t=2020. COVID-19 and VIH |pdf=|usr=}}{{33012892}} gab.com Text COVID-19 and VIH JO: Colomb Med (Cali) http://www.kidney.de/pget.php?&tw=1&pmid=33012892 #FOAvip Throughout the COVID-19 pandemic, the main risk factors associated with the progression to severe disease or death have been typically advanced age, diabetes mellitus, obesity, high blood pressure, heart disease, and chronic pneumopathy. Because of their immunosuppression status, persons with HIV were also expected to have a higher susceptibility to infection or a poor clinical evolution. So far, this has not been confirmed to happen, giving way to hypotheses about the role of immunosuppression or the use of antiretrovirals, which could explain this paradox. In this article we present the existing data on the epidemiology and characteristics of HIV-COVID-19 co-infection, discuss the available evidence on the possible factors involved in the evolution of individuals affected by both viruses, analyze other determinants that may negatively affect persons with HIV during the pandemic, and present recommendations for the prevention and care of COVID-19 infection in the context of HIV. Twit Text FOAVip COVID-19 and VIH ????Colomb Med (Cali) http://www.kidney.de/pget.php?&tw=1&pmid=33012892 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33012892 #FOAvip English Wikipedia <ref>{{Cite pmid|33012892}}</ref> COVID-19 and VIH #MMPMID33012892 Posada-Vergara MP; Alzate-Angel JC; Martinez-Buitrago E Colomb Med (Cali) 2020[Jun]; 51 (2): e4327 PMID33012892show ga Throughout the COVID-19 pandemic, the main risk factors associated with the progression to severe disease or death have been typically advanced age, diabetes mellitus, obesity, high blood pressure, heart disease, and chronic pneumopathy. Because of their immunosuppression status, persons with HIV were also expected to have a higher susceptibility to infection or a poor clinical evolution. So far, this has not been confirmed to happen, giving way to hypotheses about the role of immunosuppression or the use of antiretrovirals, which could explain this paradox. In this article we present the existing data on the epidemiology and characteristics of HIV-COVID-19 co-infection, discuss the available evidence on the possible factors involved in the evolution of individuals affected by both viruses, analyze other determinants that may negatively affect persons with HIV during the pandemic, and present recommendations for the prevention and care of COVID-19 infection in the context of HIV. |COVID-19[MESH] |Coinfection[MESH] |Coronavirus Infections/*epidemiology/prevention & control[MESH] |Disease Progression[MESH] |HIV Infections/*epidemiology/virology[MESH] |Humans[MESH] |Pandemics/prevention & control[MESH] |Pneumonia, Viral/*epidemiology/prevention & control[MESH]COVID-19 and VIH (epmc).pdf DeepDyve Pubget Overpricing